Translational Oncology Research LLC is categorized under Research and Development Laboratories in Longmont, CO and active since 2010.
Translational Oncology Research LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Steve Mitchell at the company’s single location by writing to 2671 Elmer Linn Drive, Longmont, Colorado CO 80504 or by phoning (303) 651-1101. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Translational Oncology Research LLC |
Contact Person: | Steve Mitchell |
Address: | 2671 Elmer Linn Drive, Longmont, Colorado 80504 |
Phone Number: | (303) 651-1101 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Translational Oncology Research LLC was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Steve Mitchell for inquiries that concern Translational Oncology Research LLC by calling the company number (303) 651-1101, as your correspondence is most welcome. Additionally, the physical location of the single location of Translational Oncology Research LLC can be found at the coordinates 40.168695,-105.010575 as well as the street address 2671 Elmer Linn Drive in Longmont, Colorado 80504.
For its online presence, you may visit Translational Oncology Research LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.